Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing paracetamol and phenyltoloxamine citrate and salicylamide |
Is a |
Product containing paracetamol and phenyltoloxamine citrate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing paracetamol and phenyltoloxamine citrate and salicylamide |
Is a |
Product containing salicylamide (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing paracetamol and phenyltoloxamine citrate and salicylamide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Salicylamide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing paracetamol and phenyltoloxamine citrate and salicylamide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethanolamine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing paracetamol and phenyltoloxamine citrate and salicylamide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Paracetamol |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing paracetamol and phenyltoloxamine citrate and salicylamide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenyltoloxamine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing paracetamol and phenyltoloxamine citrate and salicylamide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenyltoloxamine citrate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing paracetamol and phenyltoloxamine citrate and salicylamide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cardiovasculaire |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|